[ad_1]
NEW DELHI: The untimely demise of actor and model Poonam Pandey, who passed away at the age of 32 due to cervical cancer, has brought attention to the urgency of addressing cervical cancer, a concern prevalent in India.
Cervical cancer has been a pressing issue in India, accounting for a third of all global cervical cancer deaths, with around 1,32,000 new cases diagnosed annually.
In the context of this health concern, finance minister Nirmala Sitharaman on Thursday addressed significant initiatives in the interim Budget for 2024-2025. The Union health ministry has received a substantial allocation of Rs 90,658.63 crore, indicating a 12.59% increase from the previous fiscal year.
Specifically addressing cervical cancer, Sitharaman outlined measures for prevention, including the promotion of cervical cancer vaccination for girls aged 9-14. With India facing a significant burden of cervical cancer cases, this proactive approach seeks to protect young girls from preventable diseases and deaths.
The budget also allocates resources for the promotion of bulk drug parks, underlining the importance of bolstering India’s bulk drug manufacturing capabilities.
Besides, Sitharaman emphasized the government’s commitment to promoting research and development in the life sciences sector. One notable initiative is the plan to establish more medical colleges by utilizing existing hospital infrastructure.
As part of the broader budgetary focus, Sitharaman also unveiled programs like Saksham Anganwadi and Poshan 2.0, designed to improve nutrition delivery and early childhood care and development.
Meanhwile, WHO representative to India Dr Roderico H Ofrin said the initiatives announced by the government will help strengthen healthcare services across the country. “The initiatives announced today, including upgrading existing hospital infrastructure to increase medical colleges, harmonisation of maternal and child care implementation, introduction of HPV vaccination for cervical cancer prevention and the expansion of the U-WIN platform across for managing and intensifying immunisation, will further strengthen systems and healthcare services across the country,” Ofrin said.
Serum Institute of India (SII) CEO Adar Poonawalla also hailed the government’s announcements, saying, “I applaud the announcement to vaccinate girls aged 9-14 against cervical cancer. Let’s pledge to prevent HPV (Human Papillomavirus) and ensure easy access to vaccination.”
Cervical cancer has been a pressing issue in India, accounting for a third of all global cervical cancer deaths, with around 1,32,000 new cases diagnosed annually.
In the context of this health concern, finance minister Nirmala Sitharaman on Thursday addressed significant initiatives in the interim Budget for 2024-2025. The Union health ministry has received a substantial allocation of Rs 90,658.63 crore, indicating a 12.59% increase from the previous fiscal year.
Specifically addressing cervical cancer, Sitharaman outlined measures for prevention, including the promotion of cervical cancer vaccination for girls aged 9-14. With India facing a significant burden of cervical cancer cases, this proactive approach seeks to protect young girls from preventable diseases and deaths.
The budget also allocates resources for the promotion of bulk drug parks, underlining the importance of bolstering India’s bulk drug manufacturing capabilities.
Besides, Sitharaman emphasized the government’s commitment to promoting research and development in the life sciences sector. One notable initiative is the plan to establish more medical colleges by utilizing existing hospital infrastructure.
As part of the broader budgetary focus, Sitharaman also unveiled programs like Saksham Anganwadi and Poshan 2.0, designed to improve nutrition delivery and early childhood care and development.
Meanhwile, WHO representative to India Dr Roderico H Ofrin said the initiatives announced by the government will help strengthen healthcare services across the country. “The initiatives announced today, including upgrading existing hospital infrastructure to increase medical colleges, harmonisation of maternal and child care implementation, introduction of HPV vaccination for cervical cancer prevention and the expansion of the U-WIN platform across for managing and intensifying immunisation, will further strengthen systems and healthcare services across the country,” Ofrin said.
Serum Institute of India (SII) CEO Adar Poonawalla also hailed the government’s announcements, saying, “I applaud the announcement to vaccinate girls aged 9-14 against cervical cancer. Let’s pledge to prevent HPV (Human Papillomavirus) and ensure easy access to vaccination.”
[ad_2]
Source link